![](/img/cover-not-exists.png)
Pharmacological and structural characterizations of naquotinib, a novel third generation EGFR tyrosine kinase inhibitor, in EGFR mutated non-small-cell lung cancer
Hirano, Toshiyuki, Yasuda, Hiroyuki, Hamamoto, Junko, Nukaga, Shigenari, Masuzawa, Keita, Kawada, Ichiro, Naoki, Katsuhiko, Niimi, Tatsuya, Mimasu, Shinya, Sakagami, Hideki, Soejima, Kenzo, Betsuyaku,Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-1033
Date:
February, 2018
File:
PDF, 4.82 MB
english, 2018